LDL Susceptibility to copper-induced oxidation after administration of a single dose of free or esterified beta-cryptoxanthin

Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/2737
dc.identifier.uri http://www.repo.uni-hannover.de/handle/123456789/2763
dc.contributor.author Wolters, Maike
dc.contributor.author Hahn, Andreas
dc.date.accessioned 2018-02-09T09:27:53Z
dc.date.available 2018-02-09T09:27:53Z
dc.date.issued 2004
dc.identifier.citation Wolters, M.; Hahn, A.: LDL Susceptibility to copper-induced oxidation after administration of a single dose of free or esterified beta-cryptoxanthin. In: Annals of Nutrition and Metabolism 48 (2004), Nr. 3, S. 163-168. DOI: https://doi.org/10.1159/000078380
dc.description.abstract Background: The oxidative modification of LDL is believed to be an initial step in atherosclerosis. Thus, antioxidative substances such as carotenoids may have a role in the prevention of coronary heart disease. We examined the susceptibility of LDL to Cu2+ oxidation in young adults before and after a single dose of β-cryptoxanthin. Methods: 1.3 mg of β-cryptoxanthin was administered to 12 apparently healthy young volunteers. Six of the volunteers received esters, the other six free β-cryptoxanthin. The plasma concentration of β-cryptoxanthin and the susceptibility of LDL to copper-induced oxidation ex vivo in terms of the duration of lag time were measured before and 12 h after β-cryptoxanthin ingestion. Results: A single dose of β-cryptoxanthin significantly increased the mean plasma β-cryptoxanthin concentration and the mean cholesterol adjusted β-cryptoxanthin concentration by 117 and 133%, respectively. No effect on the length of lag time was assessed. However, in LDL isolated from plasma 12 h after β-cryptoxanthin administration the lengths of lag time correlated significantly with the plasma β-cryptoxanthin concentration and with the cholesterol adjusted β-cryptoxanthin levels. The lag time did not differ significantly between volunteers who received esters and those who received the same dosage as free β-cryptoxanthin. At both measuring points, smokers, male volunteers and women using oral contraceptives tended to exhibit lower β-cryptoxanthin concentrations and lower cholesterol adjusted β-cryptoxanthin concentrations as well as increased LDL oxidizability compared to nonsmokers and women not using oral contraceptives. Conclusion: A single dose of β-cryptoxanthin does not enhance the duration of LDL lag time ex vivo in healthy young subjects. Copyright © 2004 S. Karger AG, Basel. eng
dc.language.iso eng
dc.publisher Basel : S. Karger AG
dc.relation.ispartofseries Annals of Nutrition and Metabolism 48 (2004), Nr. 3
dc.rights Es gilt deutsches Urheberrecht. Das Dokument darf zum eigenen Gebrauch kostenfrei genutzt, aber nicht im Internet bereitgestellt oder an Außenstehende weitergegeben werden. Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
dc.subject Beta-cryptoxanthin eng
dc.subject Beta-cryptoxanthin ester eng
dc.subject Low-density lipoprotein eng
dc.subject Low-density lipoprotein oxidation eng
dc.subject beta cryptoxanthin eng
dc.subject cholesterol eng
dc.subject copper eng
dc.subject cryptoxanthin eng
dc.subject ester eng
dc.subject low density lipoprotein eng
dc.subject oral contraceptive agent eng
dc.subject unclassified drug eng
dc.subject adult eng
dc.subject article eng
dc.subject clinical trial eng
dc.subject comparative study eng
dc.subject controlled clinical trial eng
dc.subject controlled study eng
dc.subject correlation analysis eng
dc.subject drug blood level eng
dc.subject drug effect eng
dc.subject esterification eng
dc.subject female eng
dc.subject human eng
dc.subject lipid oxidation eng
dc.subject male eng
dc.subject measurement eng
dc.subject normal human eng
dc.subject oral contraception eng
dc.subject priority journal eng
dc.subject randomized controlled trial eng
dc.subject smoking eng
dc.subject statistical significance eng
dc.subject time eng
dc.subject Adult eng
dc.subject Arteriosclerosis eng
dc.subject beta Carotene eng
dc.subject Contraceptive Agents, Female eng
dc.subject Copper eng
dc.subject Esterification eng
dc.subject Female eng
dc.subject Humans eng
dc.subject Lipoproteins, LDL eng
dc.subject Male eng
dc.subject Oxidation-Reduction eng
dc.subject Smoking eng
dc.subject Time Factors eng
dc.subject Xanthophylls eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title LDL Susceptibility to copper-induced oxidation after administration of a single dose of free or esterified beta-cryptoxanthin
dc.type Article
dc.type Text
dc.relation.issn 0250-6807
dc.relation.doi https://doi.org/10.1159/000078380
dc.bibliographicCitation.issue 3
dc.bibliographicCitation.volume 48
dc.bibliographicCitation.firstPage 163
dc.bibliographicCitation.lastPage 168
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken